Lemborexant for sleep and movement in Parkinson's disease
Treatments studied
Part of Brain & nervous system, Mental health clinical trials.
This trial tests whether a medication called Lemborexant can improve sleep problems and movement symptoms in people with Parkinson's disease. If you have trouble sleeping due to insomnia and have had Parkinson's for at least 2 years, this study may help.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 50 years old or older
- You have been diagnosed with Parkinson's disease for at least 2 years
- You have significant insomnia (sleep problems) that bothers you a lot
- Your Parkinson's medications have stayed the same for the last 4 weeks
- You can read and understand Chinese
- You do not have untreated depression, anxiety, or other major psychiatric conditions
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if lemborexant, a sleep medication, can help people with both a mental health condition and insomnia. You would take the medicine as prescribed and complete questionnaires over 2 months.
This trial tests whether a medication that blocks brain chemicals involved in wakefulness can help reduce markers of nerve damage in people with insomnia. It is for adults aged 40–65 with chronic insomnia, and it aims to see if improving sleep may protect brain health.
This trial tests if the sleep medication lemborexant can help people with early-stage dementia who also have insomnia. It uses an N-of-1 design, meaning it will look at how you personally respond to the drug compared to a placebo.
This study tests if the sleep medication lemborexant can help people with opioid use disorder who also have chronic insomnia. Participants must already be taking buprenorphine (Suboxone) for at least 4 weeks. The goal is to see if better sleep improves mood and reduces opioid use.
This study tests an experimental insomnia drug called dimdazenil in people with Parkinson's disease who also have trouble sleeping. It aims to see if the drug can improve sleep without causing new side effects.
This study tests a sleep medication called lemborexant to see if it helps people who work rotating shifts sleep better and feel less sleepy during their shifts.
Hear when a new Parkinson’s disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.